No supply, no survival: why patients must be involved in global trade decisions

Authors

Institutions

Publication Details

Journal
BMJ
Published
2025-10-03
DOI
https://doi.org/10.1136/bmj.r2086
Citations
1
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

No supply, no survival: why patients must be involved in global trade decisions

Linxi Mytkolli
1 citations
BMJ
Pharmaceutical Economics and Policy
3.13
article

No supply, no survival: why patients must be involved in global trade decisions

Linxi Mytkolli
article en
1 citations

Abstract

No abstract available for this paper.
BMJVol. 391
Diabetes Canada (CA), National Patient Safety Foundation (US)
Openalex Percentile: Top 6%
Pharmaceutical Economics and Policy
3.13
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.